Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Post by kmilneon Sep 30, 2011 12:48pm

381 Views

Post# 19104473

Sell-off

I don't think Gpd is done dropping yet........looking at the chart, it looks like it needs a high volume sell off to hit bottom. If that happens I will sell something and buy more because no way is Gpd going to stay this low. The other possibility is that it may just start climbing back up today, being dragged along by the bullish sentiment.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?